Author Question: Most of the time, other actors we encounter will: a. share our frames. b. misjudge our frames. ... (Read 226 times)

torybrooks

  • Hero Member
  • *****
  • Posts: 500
Most of the time, other actors we encounter will:
 
  a. share our frames.
  b. misjudge our frames.
  c. deny our frames.
  d. renegotiate our frames.

Question 2

After framing an encounter and defining what is going on, the second question individuals must resolve is:
 
  a. What is the purpose of this interaction?
  b. Is this situation problematic or routine?
  c. Which identities pertain to this particular situation?
  d. Why am I doing this?



ntsoane kedibone

  • Sr. Member
  • ****
  • Posts: 333
Answer to Question 1

a

Answer to Question 2

c



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

There can actually be a 25-hour time difference between certain locations in the world. The International Date Line passes between the islands of Samoa and American Samoa. It is not a straight line, but "zig-zags" around various island chains. Therefore, Samoa and nearby islands have one date, while American Samoa and nearby islands are one day behind. Daylight saving time is used in some islands, but not in others—further shifting the hours out of sync with natural time.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

During pregnancy, a woman is more likely to experience bleeding gums and nosebleeds caused by hormonal changes that increase blood flow to the mouth and nose.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library